February 22, 2023 02:17 PM ESTUpdated 02:54 PM
Pharma
Manufacturing

Charles Riv­er hand­ed sub­poe­na by DOJ over non-hu­man pri­mate sup­ply

Tyler Patchen

News Reporter

Charles Riv­er Lab­o­ra­to­ries has re­ceived a sub­poe­na from the US De­part­ment of Jus­tice as part of an in­ves­ti­ga­tion in­to ship­ments of non-hu­man pri­mates from Cam­bo­dia …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Dai­ichi Sankyo finds suc­ces­sor to late R&D ex­ec; Ver­sant, No­var­tis' kid­ney biotech poach­es Sana CBO

A service from the Financial Times